Latest News

  • Xbrane reaches commercial breakthrough with the first batches of Spherotide valued at SEK 7 million

    Read more >>
  • Xbrane Biopharma AB (publ) releases interim report for the period April - June 2016

    Read more >>
  • Xbrane Biopharma AB: Oxford Nanopore Technologies licenses Xbrane Biopharma's protein production technology

    Read more >>
  • Xbrane Biopharma AB (publ) publishes shareholder letter

    Read more >>
News & Events >>

Events

  • Xbrane attending Jefferies Healthcare conference 7-10 June in New York

    Read more >>
  • Xbrane attending Bio International 6-9 June in San Francisco

    Read more >>
  • Xbrane presenting at "Nasdaq and Aktiespararna investerarkväll” 25 May in Stockholm

    Read more >>
  • Xbrane attending China Bio 18-19 May in Suzhou

    Read more >>
  • Xbrane attending BioEquity 10-11 May in Copenhagen

    Read more >>
  • Xbrane presenting at Aktiespararna aktiedag 2 May at Operaterassen in Stockholm

    Read more >>
  • Xbrane attending BioEurope 4-6 April in Stockholm

    Read more >>